THRIVENT FINANCIAL FOR LUTHERANS - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 131 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.

Quarter-by-quarter ownership
THRIVENT FINANCIAL FOR LUTHERANS ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$83,000
-68.3%
13,175
-61.1%
0.00%
-100.0%
Q1 2021$262,000
-55.8%
33,845
-62.6%
0.00%0.0%
Q4 2020$593,000
-1.5%
90,6020.0%0.00%
-50.0%
Q3 2020$602,000
+46.1%
90,602
+82.9%
0.00%
+100.0%
Q2 2020$412,000
+8.4%
49,5240.0%0.00%0.0%
Q1 2020$380,00049,5240.00%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
BVF INC/IL 5,576,471$36,526,0001.44%
Altium Capital Management LP 273,703$1,793,0000.67%
Jackson Creek Investment Advisors LLC 80,367$526,0000.21%
HARBOURVEST PARTNERS LLC 79,193$519,0000.20%
XTX MARKETS LLC 14,169$93,0000.19%
Perceptive Advisors 2,577,043$16,880,0000.18%
RTW INVESTMENTS, LP 1,527,352$10,004,0000.17%
Exane Asset Management 30,568$200,220,0000.14%
Virtus ETF Advisers LLC 37,343$245,0000.10%
Congress Park Capital LLC 25,807$169,0000.10%
View complete list of CYTOMX THERAPEUTICS INC shareholders